Prometeus will develop an innovative miniaturized on-body patch sensor for the minimally invasive continuous monitoring of the three key brain metabolites: glucose, lactate and beta-hydroxybutyrate (BHB). There are currently no neonatal metabolic sensors able to measure all three brain metabolites. All these information should provide a more detailed picture of the metabolic state of the newborn.